Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bioventus Q4 2024 Adj EPS $0.15 Beats $0.08 Estimate, Sales $153.64M Beat $145.17M Estimate

Author: Benzinga Newsdesk | March 11, 2025 06:35am
Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.08 by 87.5 percent. This is a 114.29 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $153.64 million which beat the analyst consensus estimate of $145.17 million by 5.84 percent. This is a 13.45 percent increase over sales of $135.42 million the same period last year.

Posted In: BVS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist